Lannett , Inc. Return on Equity

Lannett , Inc. (LCI) currently reports a ROE of 62.85%. That is above the Healthcare sector average of 21.67%. Use the charts on this page to explore Lannett , Inc.'s ROE history and peer comparisons.

Lannett , Inc.'s ROE of 62.85% is higher than the Healthcare sector average of 21.67%. That is roughly 190.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Lannett , Inc.'s current 62.85% should be judged against Healthcare norms (sector average: 21.67%) and against LCI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 62.85%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for Lannett , Inc., and consider following LCI for alerts when major investors trade the stock.

Lannett , Inc. is classified in the Healthcare sector. On ROE, it currently shows 62.85% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LCI with unrelated industries.